CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
Frequently asked questions
What sector does OpGen Inc (OPGN) operate in?
OpGen Inc belongs to the Healthcare sector and operates in the Capital Markets industry.
What is OpGen Inc (OPGN) current stock price?
As of the latest data, OpGen Inc stock price is $0.33, with a previous close of $0.33.
What is OpGen Inc (OPGN) current market capitalization?
OpGen Inc market cap is approximately 251.20 million.
What is OpGen Inc (OPGN) Earnings Per Share (EPS)?
The trailing EPS is $0.18.
What is OpGen Inc (OPGN) Price-to-Earnings (P/E) ratio?
OpGen Inc current P/E ratio is 1.82.
What is OpGen Inc (OPGN) EBITDA?
OpGen Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 50.37 thousand.
Does OpGen Inc (OPGN) pay dividends?
No. OpGen Inc does not pay a dividend.
What is OpGen Inc (OPGN) beta (volatility) score?
OpGen Inc has a beta of -3052.633, indicating lower volatility than the overall market.
